scispace - formally typeset
L

Lara Compton

Researcher at University of California, Davis

Publications -  7
Citations -  848

Lara Compton is an academic researcher from University of California, Davis. The author has contributed to research in topics: Simian immunodeficiency virus & Virus. The author has an hindex of 5, co-authored 6 publications receiving 834 citations. Previous affiliations of Lara Compton include California National Primate Research Center.

Papers
More filters
Journal ArticleDOI

Propagation and Dissemination of Infection after Vaginal Transmission of Simian Immunodeficiency Virus

TL;DR: It is shown that the mucosal barrier greatly limits the infection of cervicovaginal tissues, and thus the initial founder populations of infected cells are small, and that continuous seeding from an expanding source of production at the portal of entry is likely critical for the later establishment of a productive infection throughout the systemic LTs.
Journal ArticleDOI

CD8+ T-Lymphocyte Response to Major Immunodominant Epitopes after Vaginal Exposure to Simian Immunodeficiency Virus: Too Late and Too Little

TL;DR: The robust response in female reproductive tissues may be an encouraging sign that vaccines that rapidly induce high-frequency CD8+ T-lymphocyte responses might be able to prevent acquisition of HIV-1 infection by the most common route of transmission.
Journal ArticleDOI

Simian-Human Immunodeficiency Virus SHIV89.6-Induced Protection against Intravaginal Challenge with Pathogenic SIVmac239 Is Independent of the Route of Immunization and Is Associated with a Combination of Cytotoxic T-Lymphocyte and Alpha Interferon Responses

TL;DR: Attenuated primate lentivirus vaccines provide the most consistent protection against challenge with pathogenic simian immunodeficiency virus (SIV) and provide an excellent model to examine the influence of the route of immunization on challenge outcome and to study vaccine-induced protective anti-SIV immune responses.
Journal ArticleDOI

Protection against Simian Immunodeficiency Virus Vaginal Challenge by Using Sabin Poliovirus Vectors

TL;DR: The results demonstrate the efficacy of SabRV as a potential human vaccine vector, and they show that the use of a vaccine vector cocktail expressing an array of defined antigenic sequences can be an effective vaccination strategy in an outbred population.